Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort studyXianming Zhu, Aaron A.R. Tobian, Eshan U. Patel et al.|The Lancet Microbe|2023Cited by 77
Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipientsAndrew H. Karaba, William A. Werbel, Jake D. Kim et al.|American Journal of Transplantation|2023Cited by 12